Evommune, Inc. (EVMN) › RevenueEvommune, Inc. (EVMN) — RevenueAnnual figures by fiscal year, from SEC filings.2024: $7.00M2025: $13.00M$13.00M2024Revenue (USD)2025Fiscal YearRevenueChange YoY2025$13.00M+85.7%2024$7.00M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share